Workflow
QYOU Media Inc. (OTC:QYOUF) Undergoes Reverse Stock Split
Financial Modeling Prep· 2025-11-24 23:00
Core Insights - QYOU Media Inc. operates in India and the United States, focusing on creating and distributing content for younger audiences in the digital and television sectors [1] - The company underwent a reverse stock split at a ratio of 12 for 1 to streamline shares and enhance marketability [2][6] - The current stock price of QYOUF is $0.0249, reflecting a decrease of 3.49% today, with a market capitalization of approximately $14.89 million [3][4][6] - Today's trading volume for QYOUF is notably low, with only 2 shares traded, indicating limited investor interest [5][6] Company Overview - QYOU Media Inc. targets younger audiences with an innovative media approach, competing in the digital content space [1] - The company has experienced significant stock price volatility over the past year, with a high of $0.792 and a low of $0.0249 [3] Market Performance - The reverse stock split did not affect the overall market capitalization, which remains at approximately $14.89 million [4][6] - The low trading volume may impact the stock's liquidity, although a reverse stock split can sometimes improve liquidity by making the stock more attractive to investors [5]
Meta Allegedly Profited by $16B From Scam Ads. US Senators Demand FTC, SEC Probe
CNET· 2025-11-24 22:26
US Senators Josh Hawley and Richard Blumenthal are calling for an investigation into Meta over its alleged role in profiting from scam-laden advertisements on Facebook and Instagram. The demand follows a Reuters investigation reportedly based on internal Meta documents that estimated that nearly 10% of Meta's 2024 revenue -- about $16 billion -- came from alleged "illicit advertising." In a letter to the Federal Trade Commission and the Securities and Exchange Commission, the lawmakers urged regulators to " ...
Keysight beats quarterly forecast estimates on strong demand from AI data centers
Reuters· 2025-11-24 22:22
Electronic equipment maker Keysight Technologies forecast first-quarter revenue and profit ahead of Wall Street estimates on Monday, sending its shares up more than 13% in after-market trading. ...
QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
Globenewswire· 2025-11-24 22:20
RADNOR, Pa., Nov. 24, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of uniQure N.V. (NASDAQ: QURE) ("uniQure"). On November 3, 2025, uniQure issued a press release revealing that the FDA notified the company that data for its AMT-130, an investigational gene therapy for Huntington's disease, did not provide sufficient evidence to support uniQure's Biologics Licen ...
PayPal: Potential Dividend Growth Champion
Seeking Alpha· 2025-11-24 22:19
Analyst's Disclosure:I/we have a beneficial long position in the shares of PYPL either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any in ...
Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)
Globenewswire· 2025-11-24 22:16
Ad hoc announcement pursuant to Art. 53 LR Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase III studiesOne-time dose of Itvisma replaces SMN1 gene, potentially reducing the need for chronic SMA treatmentGene replacement therapy now available to eligible people of all ages living with SMA Basel, November 24, 2025 – Novartis today announced that the US Food and Drug Administration (FDA) has approved Itvisma® ...
PINE.PR.A: An 8.00% Preferred Stock IPO From Alpine Income Property
Seeking Alpha· 2025-11-24 22:16
we discuss ideas like this as they happen in more detail. All active investors are welcome to join on a free trial and ask any question in our chat room full of sophisticated traders and investors. This is another article in our series dedicated to newly listed on the exchange fixed-income securities. This time, we'll focus our attention on Alpine Income Property Trust, Inc.'s ( PINE ) latest Analyst's Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, an ...
GE HealthCare announces cash dividend for fourth quarter of 2025
Businesswire· 2025-11-24 22:15
Nov 24, 2025 5:15 PM Eastern Standard Time GE HealthCare announces cash dividend for fourth quarter of 2025 Share CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the fourth quarter of 2025 payable on February 13, 2026, to all shareholders of record as of January 9, 2026. About GE HealthCare Technologies Inc.GE HealthCare is a trusted partner and leading global healthcare solutions provid ...
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Perrigo Company plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – PRGO
Globenewswire· 2025-11-24 22:15
NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 16, 2026. SO WHAT: If you purchased Perrigo securities during the Class Period yo ...
Hall Chadwick Acquisition Corp. Completes $207 Million Initial Public Offering
Globenewswire· 2025-11-24 22:14
NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Hall Chadwick Acquisition Corp. (NASDAQ:HCACU) (the “Company”) announced the closing of its initial public offering of 20,700,000 units, which includes 2,700,000 units issued pursuant to the exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $207,000,000. The Company’s units began trading on the Nasdaq Global Market (“Nasdaq”) on November 21, 2025, under the ticker symbol “HCACU.” ...